239 related articles for article (PubMed ID: 29057463)
1. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
[TBL] [Abstract][Full Text] [Related]
2. Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule.
Xue D; Li X; Ren Y; Liu Q; Yen Y; Xue L
Int J Surg Pathol; 2015 Jun; 23(4):333-5. PubMed ID: 25633507
[TBL] [Abstract][Full Text] [Related]
3. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
[TBL] [Abstract][Full Text] [Related]
4. Myxoid variant of primary cutaneous anaplastic large cell lymphoma: First 2 cases.
Fernandez-Flores A; Eginli A; Cassarino DS
J Cutan Pathol; 2017 Sep; 44(9):772-775. PubMed ID: 28626950
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
[TBL] [Abstract][Full Text] [Related]
6. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
7. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
[TBL] [Abstract][Full Text] [Related]
11. Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Gratzinger D; Million L; Kim YH
Am J Dermatopathol; 2015 Oct; 37(10):767-70. PubMed ID: 26381026
[TBL] [Abstract][Full Text] [Related]
12. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
13. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
15. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
17. ALK Expression is a Rare Finding in Mycosis Fungoides.
Covington M; Cassarino D; Abdulla F
Am J Dermatopathol; 2017 May; 39(5):342-343. PubMed ID: 28426485
[TBL] [Abstract][Full Text] [Related]
18. A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma.
Lyu WT; Song QB; Qiong W; Liu J; Yong R; Yi FT; Han DL
Medicine (Baltimore); 2021 May; 100(18):e25770. PubMed ID: 33950967
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Daniëls LA; Neelis KJ; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Velstra B; Veraart JCJM; Roach REJ; Vermeer MH; Quint KD
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1279-1285. PubMed ID: 28958772
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous anaplastic large cell lymphoma in a child simulating primary cutaneous Hodgkin's disease.
Mahajan VK; Jindal R
Indian J Dermatol Venereol Leprol; 2016; 82(1):98-101. PubMed ID: 26728828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
